Sicagen India Limited

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AEGISLOG.BO has a market cap of 210.1B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AEGISLOG.BO trades at ₹598.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AEGISLOG.BO's P/E ratio is 27.26. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AEGISLOG.BO's ROE of +0.15%. Regarding short-term risk, SICAGEN.BO is more volatile compared to AEGISLOG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AEGISLOG.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SGMART.NS has a market cap of 58.4B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SGMART.NS trades at ₹463.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SGMART.NS's P/E ratio is 54.94. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SGMART.NS's ROE of +0.08%. Regarding short-term risk, SICAGEN.BO is less volatile compared to SGMART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check SGMART.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, LLOYDSENT.BO has a market cap of 52.7B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while LLOYDSENT.BO trades at ₹41.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas LLOYDSENT.BO's P/E ratio is 18.15. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to LLOYDSENT.BO's ROE of +0.09%. Regarding short-term risk, SICAGEN.BO is more volatile compared to LLOYDSENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check LLOYDSENT.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, VINCOFE.BO has a market cap of 19.1B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while VINCOFE.BO trades at ₹132.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas VINCOFE.BO's P/E ratio is 28.03. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to VINCOFE.BO's ROE of +0.19%. Regarding short-term risk, SICAGEN.BO is more volatile compared to VINCOFE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check VINCOFE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, EFCIL.BO has a market cap of 17.8B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while EFCIL.BO trades at ₹178.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas EFCIL.BO's P/E ratio is 11.16. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to EFCIL.BO's ROE of +0.31%. Regarding short-term risk, SICAGEN.BO is more volatile compared to EFCIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check EFCIL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, KHAZANCHI.BO has a market cap of 15.5B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while KHAZANCHI.BO trades at ₹625.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas KHAZANCHI.BO's P/E ratio is 20.31. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to KHAZANCHI.BO's ROE of +0.29%. Regarding short-term risk, SICAGEN.BO is more volatile compared to KHAZANCHI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check KHAZANCHI.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, TCC.BO has a market cap of 11.3B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while TCC.BO trades at ₹317.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas TCC.BO's P/E ratio is 26.81. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to TCC.BO's ROE of +0.07%. Regarding short-term risk, SICAGEN.BO is more volatile compared to TCC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check TCC.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, YSL.BO has a market cap of 8.3B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while YSL.BO trades at ₹27,000.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas YSL.BO's P/E ratio is 7.58. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to YSL.BO's ROE of +0.09%. Regarding short-term risk, SICAGEN.BO is more volatile compared to YSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check YSL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, CROPSTER.BO has a market cap of 4.6B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while CROPSTER.BO trades at ₹5.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas CROPSTER.BO's P/E ratio is 1.29. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to CROPSTER.BO's ROE of +0.15%. Regarding short-term risk, SICAGEN.BO is more volatile compared to CROPSTER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check CROPSTER.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PRIZOR.NS has a market cap of 4.3B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PRIZOR.NS trades at ₹405.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PRIZOR.NS's P/E ratio is 36.59. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PRIZOR.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to PRIZOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PRIZOR.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, EUROASIA.BO has a market cap of 4.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while EUROASIA.BO trades at ₹306.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas EUROASIA.BO's P/E ratio is N/A. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to EUROASIA.BO's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to EUROASIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check EUROASIA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MERCURYEV.BO has a market cap of 3.9B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MERCURYEV.BO trades at ₹20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MERCURYEV.BO's P/E ratio is 78.19. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MERCURYEV.BO's ROE of +0.02%. Regarding short-term risk, SICAGEN.BO is less volatile compared to MERCURYEV.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check MERCURYEV.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AERPACE.BO has a market cap of 3.6B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AERPACE.BO trades at ₹23.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AERPACE.BO's P/E ratio is -36.34. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AERPACE.BO's ROE of -0.22%. Regarding short-term risk, SICAGEN.BO is more volatile compared to AERPACE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AERPACE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, VERITAS.BO has a market cap of 3.6B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while VERITAS.BO trades at ₹134.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas VERITAS.BO's P/E ratio is 10.47. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to VERITAS.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to VERITAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check VERITAS.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, BLACKROSE.BO has a market cap of 3.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while BLACKROSE.BO trades at ₹63.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas BLACKROSE.BO's P/E ratio is 24.68. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to BLACKROSE.BO's ROE of +0.12%. Regarding short-term risk, SICAGEN.BO is less volatile compared to BLACKROSE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check BLACKROSE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SWISSMLTRY.BO has a market cap of 3.1B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SWISSMLTRY.BO trades at ₹13.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SWISSMLTRY.BO's P/E ratio is 38.29. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SWISSMLTRY.BO's ROE of +0.07%. Regarding short-term risk, SICAGEN.BO is less volatile compared to SWISSMLTRY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check SWISSMLTRY.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SRD.BO has a market cap of 2.5B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SRD.BO trades at ₹39.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SRD.BO's P/E ratio is 22.30. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SRD.BO's ROE of +0.10%. Regarding short-term risk, SICAGEN.BO is less volatile compared to SRD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check SRD.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MARBLE.BO has a market cap of 2.3B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MARBLE.BO trades at ₹96.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MARBLE.BO's P/E ratio is 22.55. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MARBLE.BO's ROE of +0.18%. Regarding short-term risk, SICAGEN.BO is more volatile compared to MARBLE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check MARBLE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, WARDWIZFBL.BO has a market cap of 2.3B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while WARDWIZFBL.BO trades at ₹8.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas WARDWIZFBL.BO's P/E ratio is -220.50. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to WARDWIZFBL.BO's ROE of -0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to WARDWIZFBL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check WARDWIZFBL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ANLON.NS has a market cap of 2.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ANLON.NS trades at ₹357.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ANLON.NS's P/E ratio is 33.82. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ANLON.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to ANLON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ANLON.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SAMOR.BO has a market cap of 1.8B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SAMOR.BO trades at ₹77.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SAMOR.BO's P/E ratio is 161.75. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SAMOR.BO's ROE of -0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to SAMOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SAMOR.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PARSHVA.BO has a market cap of 1.7B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PARSHVA.BO trades at ₹163.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PARSHVA.BO's P/E ratio is 815.00. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PARSHVA.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to PARSHVA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PARSHVA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ABANSENT.BO has a market cap of 1.4B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ABANSENT.BO trades at ₹20.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ABANSENT.BO's P/E ratio is 8.72. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ABANSENT.BO's ROE of +0.08%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ABANSENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ABANSENT.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, VISAMAN.NS has a market cap of 1.4B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while VISAMAN.NS trades at ₹99.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas VISAMAN.NS's P/E ratio is 60.06. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to VISAMAN.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to VISAMAN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check VISAMAN.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, METROGLOBL.BO has a market cap of 1.3B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while METROGLOBL.BO trades at ₹105.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas METROGLOBL.BO's P/E ratio is 13.17. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to METROGLOBL.BO's ROE of +0.03%. Regarding short-term risk, SICAGEN.BO is less volatile compared to METROGLOBL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check METROGLOBL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, DENEERS.NS has a market cap of 1.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while DENEERS.NS trades at ₹144.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas DENEERS.NS's P/E ratio is 7.88. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to DENEERS.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to DENEERS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check DENEERS.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MAXIMUS.BO has a market cap of 1.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MAXIMUS.BO trades at ₹9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MAXIMUS.BO's P/E ratio is 13.43. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MAXIMUS.BO's ROE of +0.12%. Regarding short-term risk, SICAGEN.BO is more volatile compared to MAXIMUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check MAXIMUS.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SILKFLEX.NS has a market cap of 1.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SILKFLEX.NS trades at ₹103.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SILKFLEX.NS's P/E ratio is 15.98. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SILKFLEX.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to SILKFLEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SILKFLEX.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, BNL.BO has a market cap of 1.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while BNL.BO trades at ₹118.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas BNL.BO's P/E ratio is 30.44. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to BNL.BO's ROE of +0.05%. Regarding short-term risk, SICAGEN.BO is more volatile compared to BNL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check BNL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SEML.BO has a market cap of 1.2B. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SEML.BO trades at ₹74.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SEML.BO's P/E ratio is 13.07. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SEML.BO's ROE of +0.12%. Regarding short-term risk, SICAGEN.BO is more volatile compared to SEML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SEML.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MENAMANI.BO has a market cap of 990.4M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MENAMANI.BO trades at ₹9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MENAMANI.BO's P/E ratio is -246.75. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MENAMANI.BO's ROE of +0.52%. Regarding short-term risk, SICAGEN.BO is more volatile compared to MENAMANI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check MENAMANI.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ISHANCH.BO has a market cap of 980.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ISHANCH.BO trades at ₹46.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ISHANCH.BO's P/E ratio is -10.81. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ISHANCH.BO's ROE of -0.09%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ISHANCH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ISHANCH.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, CHANDRIMA.BO has a market cap of 959.2M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while CHANDRIMA.BO trades at ₹4.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas CHANDRIMA.BO's P/E ratio is -3.19. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to CHANDRIMA.BO's ROE of +0.04%. Regarding short-term risk, SICAGEN.BO is more volatile compared to CHANDRIMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check CHANDRIMA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, GEL.BO has a market cap of 887.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while GEL.BO trades at ₹288.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas GEL.BO's P/E ratio is 1028.57. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to GEL.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to GEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check GEL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, OPTIFIN.BO has a market cap of 887M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while OPTIFIN.BO trades at ₹11.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas OPTIFIN.BO's P/E ratio is 15.83. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to OPTIFIN.BO's ROE of +0.07%. Regarding short-term risk, SICAGEN.BO is less volatile compared to OPTIFIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check OPTIFIN.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, DHOOTIN.BO has a market cap of 874.1M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while DHOOTIN.BO trades at ₹138.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas DHOOTIN.BO's P/E ratio is -52.01. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to DHOOTIN.BO's ROE of -0.00%. Regarding short-term risk, SICAGEN.BO is less volatile compared to DHOOTIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check DHOOTIN.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PURVFLEXI.NS has a market cap of 800.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PURVFLEXI.NS trades at ₹38.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PURVFLEXI.NS's P/E ratio is 7.69. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PURVFLEXI.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to PURVFLEXI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PURVFLEXI.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SANINFRA.BO has a market cap of 794.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SANINFRA.BO trades at ₹5.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SANINFRA.BO's P/E ratio is 41.92. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SANINFRA.BO's ROE of +0.05%. Regarding short-term risk, SICAGEN.BO is less volatile compared to SANINFRA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check SANINFRA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, INDXTRA.BO has a market cap of 744.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while INDXTRA.BO trades at ₹5.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas INDXTRA.BO's P/E ratio is -28.55. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to INDXTRA.BO's ROE of -0.02%. Regarding short-term risk, SICAGEN.BO is less volatile compared to INDXTRA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check INDXTRA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ROCKINGDCE.NS has a market cap of 738.2M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ROCKINGDCE.NS trades at ₹130.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ROCKINGDCE.NS's P/E ratio is 15.83. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ROCKINGDCE.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to ROCKINGDCE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ROCKINGDCE.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MRCAGRO.BO has a market cap of 675.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MRCAGRO.BO trades at ₹32.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MRCAGRO.BO's P/E ratio is 65.94. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MRCAGRO.BO's ROE of +0.03%. Regarding short-term risk, SICAGEN.BO is less volatile compared to MRCAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check MRCAGRO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, RAFL.BO has a market cap of 649M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while RAFL.BO trades at ₹54.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas RAFL.BO's P/E ratio is 11.59. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to RAFL.BO's ROE of +0.07%. Regarding short-term risk, SICAGEN.BO is more volatile compared to RAFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check RAFL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, KTIL.BO has a market cap of 638.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while KTIL.BO trades at ₹58.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas KTIL.BO's P/E ratio is -2.24. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to KTIL.BO's ROE of +1.00%. Regarding short-term risk, SICAGEN.BO is more volatile compared to KTIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check KTIL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, CONSTRONIC.BO has a market cap of 614.2M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while CONSTRONIC.BO trades at ₹49.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas CONSTRONIC.BO's P/E ratio is 20.68. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to CONSTRONIC.BO's ROE of +0.10%. Regarding short-term risk, SICAGEN.BO is less volatile compared to CONSTRONIC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check CONSTRONIC.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MISHKA.BO has a market cap of 577.4M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MISHKA.BO trades at ₹39.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MISHKA.BO's P/E ratio is 41.20. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MISHKA.BO's ROE of +0.06%. Regarding short-term risk, SICAGEN.BO is more volatile compared to MISHKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check MISHKA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MYSORPETRO.BO has a market cap of 527.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MYSORPETRO.BO trades at ₹80.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MYSORPETRO.BO's P/E ratio is 1335.00. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MYSORPETRO.BO's ROE of +0.00%. Regarding short-term risk, SICAGEN.BO is more volatile compared to MYSORPETRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check MYSORPETRO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, HRYNSHP.BO has a market cap of 525.7M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while HRYNSHP.BO trades at ₹85.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas HRYNSHP.BO's P/E ratio is 13.79. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to HRYNSHP.BO's ROE of +0.07%. Regarding short-term risk, SICAGEN.BO is less volatile compared to HRYNSHP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check HRYNSHP.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, RONI.BO has a market cap of 505.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while RONI.BO trades at ₹44.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas RONI.BO's P/E ratio is 63.78. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to RONI.BO's ROE of +0.05%. Regarding short-term risk, SICAGEN.BO is less volatile compared to RONI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check RONI.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, NVENTURES.BO has a market cap of 495M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while NVENTURES.BO trades at ₹106.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas NVENTURES.BO's P/E ratio is 203.85. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to NVENTURES.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to NVENTURES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check NVENTURES.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SSTL.BO has a market cap of 454.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SSTL.BO trades at ₹18.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SSTL.BO's P/E ratio is 17.33. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SSTL.BO's ROE of +0.10%. Regarding short-term risk, SICAGEN.BO is more volatile compared to SSTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SSTL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, TAVERNIER.BO has a market cap of 415.9M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while TAVERNIER.BO trades at ₹69.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas TAVERNIER.BO's P/E ratio is 11.99. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to TAVERNIER.BO's ROE of +0.47%. Regarding short-term risk, SICAGEN.BO is more volatile compared to TAVERNIER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check TAVERNIER.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, IFL.BO has a market cap of 386M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while IFL.BO trades at ₹0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas IFL.BO's P/E ratio is 3.44. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to IFL.BO's ROE of +0.09%. Regarding short-term risk, SICAGEN.BO is less volatile compared to IFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check IFL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PALCO.BO has a market cap of 375.4M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PALCO.BO trades at ₹93.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PALCO.BO's P/E ratio is -268.14. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PALCO.BO's ROE of +0.17%. Regarding short-term risk, SICAGEN.BO is less volatile compared to PALCO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check PALCO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AAPLUSTRAD.BO has a market cap of 347.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AAPLUSTRAD.BO trades at ₹1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AAPLUSTRAD.BO's P/E ratio is 6.22. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AAPLUSTRAD.BO's ROE of +0.02%. Regarding short-term risk, SICAGEN.BO is more volatile compared to AAPLUSTRAD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AAPLUSTRAD.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, VEL.BO has a market cap of 334.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while VEL.BO trades at ₹39.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas VEL.BO's P/E ratio is -12.69. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to VEL.BO's ROE of -0.30%. Regarding short-term risk, SICAGEN.BO is less volatile compared to VEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check VEL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, YASHINNO.BO has a market cap of 333.7M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while YASHINNO.BO trades at ₹49.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas YASHINNO.BO's P/E ratio is 4950.00. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to YASHINNO.BO's ROE of +0.12%. Regarding short-term risk, SICAGEN.BO is more volatile compared to YASHINNO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check YASHINNO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, CCAL.BO has a market cap of 307.1M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while CCAL.BO trades at ₹18.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas CCAL.BO's P/E ratio is -6.67. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to CCAL.BO's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to CCAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check CCAL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ACEMEN.BO has a market cap of 290.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ACEMEN.BO trades at ₹91.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ACEMEN.BO's P/E ratio is 2282.50. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ACEMEN.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ACEMEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ACEMEN.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, OPCHAINS.BO has a market cap of 212.4M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while OPCHAINS.BO trades at ₹31.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas OPCHAINS.BO's P/E ratio is 8.59. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to OPCHAINS.BO's ROE of +0.04%. Regarding short-term risk, SICAGEN.BO is more volatile compared to OPCHAINS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check OPCHAINS.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, TTIL.BO has a market cap of 208M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while TTIL.BO trades at ₹8.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas TTIL.BO's P/E ratio is 7.15. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to TTIL.BO's ROE of +0.05%. Regarding short-term risk, SICAGEN.BO is more volatile compared to TTIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check TTIL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AGARWALFT.NS has a market cap of 204.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AGARWALFT.NS trades at ₹23.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AGARWALFT.NS's P/E ratio is 5.65. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AGARWALFT.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to AGARWALFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AGARWALFT.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PRADHIN.BO has a market cap of 203M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PRADHIN.BO trades at ₹0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PRADHIN.BO's P/E ratio is 0.40. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PRADHIN.BO's ROE of +0.10%. Regarding short-term risk, SICAGEN.BO is more volatile compared to PRADHIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PRADHIN.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, NEERAJ.BO has a market cap of 173.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while NEERAJ.BO trades at ₹15.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas NEERAJ.BO's P/E ratio is 92.65. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to NEERAJ.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to NEERAJ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check NEERAJ.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, RAMAPETRO.BO has a market cap of 160.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while RAMAPETRO.BO trades at ₹15.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas RAMAPETRO.BO's P/E ratio is -2.43. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to RAMAPETRO.BO's ROE of +0.12%. Regarding short-term risk, SICAGEN.BO is more volatile compared to RAMAPETRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check RAMAPETRO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PANTH.BO has a market cap of 160.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PANTH.BO trades at ₹6.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PANTH.BO's P/E ratio is 1.38. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PANTH.BO's ROE of +0.72%. Regarding short-term risk, SICAGEN.BO is less volatile compared to PANTH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check PANTH.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, RAWEDGE.BO has a market cap of 160.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while RAWEDGE.BO trades at ₹15.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas RAWEDGE.BO's P/E ratio is -13.07. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to RAWEDGE.BO's ROE of -0.06%. Regarding short-term risk, SICAGEN.BO is more volatile compared to RAWEDGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check RAWEDGE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SANBLUE.BO has a market cap of 156.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SANBLUE.BO trades at ₹31.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SANBLUE.BO's P/E ratio is 65.35. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SANBLUE.BO's ROE of +0.00%. Regarding short-term risk, SICAGEN.BO is more volatile compared to SANBLUE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SANBLUE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ASPIRE.NS has a market cap of 154.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ASPIRE.NS trades at ₹10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ASPIRE.NS's P/E ratio is 4.03. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ASPIRE.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to ASPIRE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ASPIRE.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, NIVAKA.BO has a market cap of 153M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while NIVAKA.BO trades at ₹1.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas NIVAKA.BO's P/E ratio is -2.57. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to NIVAKA.BO's ROE of -0.15%. Regarding short-term risk, SICAGEN.BO is more volatile compared to NIVAKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check NIVAKA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, GANONPRO.BO has a market cap of 145.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while GANONPRO.BO trades at ₹15.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas GANONPRO.BO's P/E ratio is 311.40. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to GANONPRO.BO's ROE of +0.03%. Regarding short-term risk, SICAGEN.BO is more volatile compared to GANONPRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check GANONPRO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ALCHCORP.BO has a market cap of 142.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ALCHCORP.BO trades at ₹28.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ALCHCORP.BO's P/E ratio is -13.24. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ALCHCORP.BO's ROE of -0.25%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ALCHCORP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ALCHCORP.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SAENTER.BO has a market cap of 136M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SAENTER.BO trades at ₹34.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SAENTER.BO's P/E ratio is 6.51. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SAENTER.BO's ROE of +0.22%. Regarding short-term risk, SICAGEN.BO is more volatile compared to SAENTER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SAENTER.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, TAIIND.BO has a market cap of 133.7M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while TAIIND.BO trades at ₹22.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas TAIIND.BO's P/E ratio is 278.50. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to TAIIND.BO's ROE of +0.00%. Regarding short-term risk, SICAGEN.BO is less volatile compared to TAIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check TAIIND.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, FRONTCORP.BO has a market cap of 126M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while FRONTCORP.BO trades at ₹25.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas FRONTCORP.BO's P/E ratio is -15.35. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to FRONTCORP.BO's ROE of +0.21%. Regarding short-term risk, SICAGEN.BO is more volatile compared to FRONTCORP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check FRONTCORP.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PMTELELIN.BO has a market cap of 122.9M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PMTELELIN.BO trades at ₹12.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PMTELELIN.BO's P/E ratio is -152.50. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PMTELELIN.BO's ROE of -0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to PMTELELIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PMTELELIN.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SIBARAUT.BO has a market cap of 121.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SIBARAUT.BO trades at ₹7.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SIBARAUT.BO's P/E ratio is -17.95. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SIBARAUT.BO's ROE of -0.08%. Regarding short-term risk, SICAGEN.BO is less volatile compared to SIBARAUT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check SIBARAUT.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, REETECH.BO has a market cap of 119.7M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while REETECH.BO trades at ₹28.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas REETECH.BO's P/E ratio is -2.23. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to REETECH.BO's ROE of -0.37%. Regarding short-term risk, SICAGEN.BO is more volatile compared to REETECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check REETECH.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, MULLER.BO has a market cap of 119M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while MULLER.BO trades at ₹190.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas MULLER.BO's P/E ratio is -63.68. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to MULLER.BO's ROE of +0.11%. Regarding short-term risk, SICAGEN.BO is more volatile compared to MULLER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check MULLER.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, COMPUPN.BO has a market cap of 114.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while COMPUPN.BO trades at ₹3.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas COMPUPN.BO's P/E ratio is -63.67. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to COMPUPN.BO's ROE of -0.02%. Regarding short-term risk, SICAGEN.BO is more volatile compared to COMPUPN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check COMPUPN.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PANKAJPIYUS.BO has a market cap of 113.8M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PANKAJPIYUS.BO trades at ₹284.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PANKAJPIYUS.BO's P/E ratio is 21.26. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PANKAJPIYUS.BO's ROE of -0.00%. Regarding short-term risk, SICAGEN.BO is more volatile compared to PANKAJPIYUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PANKAJPIYUS.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SAROJA.NS has a market cap of 112.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SAROJA.NS trades at ₹28.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SAROJA.NS's P/E ratio is 10.89. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SAROJA.NS's ROE of N/A. Regarding short-term risk, SICAGEN.BO is more volatile compared to SAROJA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SAROJA.NS's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AIHL.BO has a market cap of 100.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AIHL.BO trades at ₹47.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AIHL.BO's P/E ratio is 3.47. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AIHL.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to AIHL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AIHL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, SRUSTEELS.BO has a market cap of 85.1M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while SRUSTEELS.BO trades at ₹1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas SRUSTEELS.BO's P/E ratio is 4.30. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to SRUSTEELS.BO's ROE of +0.04%. Regarding short-term risk, SICAGEN.BO is more volatile compared to SRUSTEELS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check SRUSTEELS.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, 7NR.BO has a market cap of 84.9M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while 7NR.BO trades at ₹3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas 7NR.BO's P/E ratio is 4.81. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to 7NR.BO's ROE of +0.06%. Regarding short-term risk, SICAGEN.BO is less volatile compared to 7NR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check 7NR.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ELEFLOR.BO has a market cap of 83M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ELEFLOR.BO trades at ₹4.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ELEFLOR.BO's P/E ratio is 3.55. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ELEFLOR.BO's ROE of +0.10%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ELEFLOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ELEFLOR.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, FRASER.BO has a market cap of 80.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while FRASER.BO trades at ₹9.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas FRASER.BO's P/E ratio is -8.49. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to FRASER.BO's ROE of -0.17%. Regarding short-term risk, SICAGEN.BO is more volatile compared to FRASER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check FRASER.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PARKERAC.BO has a market cap of 76M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PARKERAC.BO trades at ₹15.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PARKERAC.BO's P/E ratio is 11.20. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PARKERAC.BO's ROE of +0.17%. Regarding short-term risk, SICAGEN.BO is more volatile compared to PARKERAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PARKERAC.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AMANAYA.BO has a market cap of 75.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AMANAYA.BO trades at ₹20.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AMANAYA.BO's P/E ratio is 38.85. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AMANAYA.BO's ROE of +0.05%. Regarding short-term risk, SICAGEN.BO is more volatile compared to AMANAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AMANAYA.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, DEVINE.BO has a market cap of 74M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while DEVINE.BO trades at ₹7.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas DEVINE.BO's P/E ratio is 64.67. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to DEVINE.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to DEVINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check DEVINE.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ENTRINT.BO has a market cap of 65.2M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ENTRINT.BO trades at ₹21.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ENTRINT.BO's P/E ratio is -70.52. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ENTRINT.BO's ROE of -0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ENTRINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ENTRINT.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, KONNDOR.BO has a market cap of 65.2M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while KONNDOR.BO trades at ₹11.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas KONNDOR.BO's P/E ratio is -40.72. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to KONNDOR.BO's ROE of -0.00%. Regarding short-term risk, SICAGEN.BO is more volatile compared to KONNDOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check KONNDOR.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, FLORACORP.BO has a market cap of 63.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while FLORACORP.BO trades at ₹7.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas FLORACORP.BO's P/E ratio is -1.64. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to FLORACORP.BO's ROE of -7.58%. Regarding short-term risk, SICAGEN.BO is more volatile compared to FLORACORP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check FLORACORP.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, AMITINT.BO has a market cap of 60.3M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while AMITINT.BO trades at ₹3.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas AMITINT.BO's P/E ratio is 45.43. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to AMITINT.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to AMITINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check AMITINT.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, ROJL.BO has a market cap of 59.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while ROJL.BO trades at ₹1.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas ROJL.BO's P/E ratio is -39.33. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to ROJL.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to ROJL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check ROJL.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, TRIVENIENT.BO has a market cap of 58.4M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while TRIVENIENT.BO trades at ₹1.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas TRIVENIENT.BO's P/E ratio is 51.00. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to TRIVENIENT.BO's ROE of -0.00%. Regarding short-term risk, SICAGEN.BO is less volatile compared to TRIVENIENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SICAGEN.BO.Check TRIVENIENT.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, WWALUM.BO has a market cap of 56.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while WWALUM.BO trades at ₹17.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas WWALUM.BO's P/E ratio is 90.53. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to WWALUM.BO's ROE of +0.01%. Regarding short-term risk, SICAGEN.BO is more volatile compared to WWALUM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check WWALUM.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, DITCO.BO has a market cap of 52.6M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while DITCO.BO trades at ₹15.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas DITCO.BO's P/E ratio is 38.10. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to DITCO.BO's ROE of +0.04%. Regarding short-term risk, SICAGEN.BO is more volatile compared to DITCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check DITCO.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, PADMAIND.BO has a market cap of 50.2M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while PADMAIND.BO trades at ₹8.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas PADMAIND.BO's P/E ratio is 63.54. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to PADMAIND.BO's ROE of -0.66%. Regarding short-term risk, SICAGEN.BO is more volatile compared to PADMAIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check PADMAIND.BO's competition here

SICAGEN.BO plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SICAGEN.BO stands at 1.7B. In comparison, VOLLF.BO has a market cap of 49.5M. Regarding current trading prices, SICAGEN.BO is priced at ₹42.78, while VOLLF.BO trades at ₹12.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SICAGEN.BO currently has a P/E ratio of 9.64, whereas VOLLF.BO's P/E ratio is -17.66. In terms of profitability, SICAGEN.BO's ROE is +0.04%, compared to VOLLF.BO's ROE of -0.02%. Regarding short-term risk, SICAGEN.BO is more volatile compared to VOLLF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SICAGEN.BO.Check VOLLF.BO's competition here